Human SLC26A6 ORF/cDNA clone-Lentivirus particle (NM_022911)

Cat. No.: vGMLP001573

Pre-made Human SLC26A6/ Lentiviral expression plasmid for SLC26A6 lentivirus packaging, SLC26A6 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to SLC26A6/ products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP001573 Human SLC26A6 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP001573
Gene Name SLC26A6
Accession Number NM_022911
Gene ID 65010
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2280 bp
Gene Alias
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGGGCTGGCGGATGCGTCGGGACCGAGGGACACACAGGCACTGCTGTCTGCAACACAAGCAATGGACCTGCGGAGGCGAGACTACCACATGGAACGGCCGCTGCTGAACCAGGAGCATTTGGAGGAGCTGGGGCGCTGGGGCTCAGCACCTAGGACCCACCAGTGGCGGACCTGGTTGCAGTGCTCCCGTGCTCGGGCCTATGCCCTTCTGCTCCAACACCTCCCGGTTTTGGTCTGGTTACCCCGGTATCCTGTGCGTGACTGGCTCCTGGGTGACCTGTTATCCGGCCTGAGTGTGGCCATCATGCAGCTTCCGCAGGGCTTGGCCTACGCCCTCCTGGCTGGATTGCCCCCCGTGTTTGGCCTCTATAGCTCCTTCTACCCTGTCTTCATCTACTTCCTGTTTGGCACTTCCCGGCACATCTCCGTGGGGACCTTTGCTGTCATGTCTGTGATGGTGGGCAGTGTGACAGAATCCCTGGCCCCGCAGGCCTTGAACGACTCCATGATCAATGAGACAGCCAGAGATGCTGCCCGGGTACAGGTGGCCTCCACACTCAGTGTCCTGGTTGGCCTCTTCCAGGTGGGGCTGGGCCTGATCCACTTCGGCTTCGTGGTCACCTACCTGTCAGAACCTCTTGTCCGAGGCTATACCACAGCTGCAGCTGTGCAGGTCTTCGTCTCACAGCTCAAGTATGTGTTTGGCCTCCATCTGAGCAGCCACTCTGGGCCACTGTCCCTCATCTATACAGTGCTGGAGGTCTGCTGGAAGCTGCCCCAGAGCAAGGTTGGCACCGTGGTCACTGCAGCTGTGGCTGGGGTGGTGCTCGTGGTGGTGAAGCTGTTGAATGACAAGCTGCAGCAGCAGCTGCCCATGCCGATACCCGGGGAGCTGCTCACGCTCATCGGGGCCACAGGCATCTCCTATGGCATGGGTCTAAAGCACAGATTTGAGGTAGATGTCGTGGGCAACATCCCTGCAGGGCTGGTGCCCCCAGTGGCCCCCAACACCCAGCTGTTCTCAAAGCTCGTGGGCAGCGCCTTCACCATCGCTGTGGTTGGGTTTGCCATTGCCATCTCACTGGGGAAGATCTTCGCCCTGAGGCACGGCTACCGGGTGGACAGCAACCAGGAGCTGGTGGCCCTGGGCCTCAGTAACCTTATCGGAGGCATCTTCCAGTGCTTCCCCGTGAGTTGCTCTATGTCTCGGAGCCTGGTACAGGAGAGCACCGGGGGCAACTCGCAGGTTGCTGGAGCCATCTCTTCCCTTTTCATCCTCCTCATCATTGTCAAACTTGGGGAACTCTTCCATGACCTGCCCAAGGCGGTCCTGGCAGCCATCATCATTGTGAACCTGAAGGGCATGCTGAGGCAGCTCAGCGACATGCGCTCCCTCTGGAAGGCCAATCGGGCGGATCTGCTTATCTGGCTGGTGACCTTCACGGCCACCATCTTGCTGAACCTGGACCTTGGCTTGGTGGTTGCGGTCATCTTCTCCCTGCTGCTCGTGGTGGTCCGGACACAGATGCCCCACTACTCTGTCCTGGGGCAGGTGCCAGACACGGATATTTACAGAGATGTGGCAGAGTACTCAGAGGCCAAGGAAGTCCGGGGGGTGAAGGTCTTCCGCTCCTCGGCCACCGTGTACTTTGCCAATGCTGAGTTCTACAGTGATGCGCTGAAGCAGAGGTGTGGTGTGGATGTCGACTTCCTCATCTCCCAGAAGAAGAAACTGCTCAAGAAGCAGGAGCAGCTGAAGCTGAAGCAACTGCAGAAAGAGGAGAAGCTTCGGAAACAGGCTGCCTCCCCCAAGGGCGCCTCAGTTTCCATTAATGTCAACACCAGCCTTGAAGACATGAGGAGCAACAACGTTGAGGACTGCAAGATGATGCAGGTGAGCTCAGGAGATAAGATGGAAGATGCAACAGCCAATGGTCAAGAAGACTCCAAGGCCCCAGATGGGTCCACACTGAAGGCCCTGGGCCTGCCTCAGCCAGACTTCCACAGCCTCATCCTGGACCTGGGTGCCCTCTCCTTTGTGGACACTGTGTGCCTCAAGAGCCTGAAGAATATTTTCCATGACTTCCGGGAGATTGAGGTGGAGGTGTACATGGCGGCCTGCCACAGCCCTGTGGTCAGCCAGCTTGAGGCTGGGCACTTCTTCGATGCATCCATCACCAAGAAGCATCTCTTTGCCTCTGTCCATGATGCTGTCACCTTTGCCCTCCAACACCCGAGGCCTGTCCCCGACAGCCCTGTTTCGGTCACCAGACTCTGA
ORF Protein Sequence MGLADASGPRDTQALLSATQAMDLRRRDYHMERPLLNQEHLEELGRWGSAPRTHQWRTWLQCSRARAYALLLQHLPVLVWLPRYPVRDWLLGDLLSGLSVAIMQLPQGLAYALLAGLPPVFGLYSSFYPVFIYFLFGTSRHISVGTFAVMSVMVGSVTESLAPQALNDSMINETARDAARVQVASTLSVLVGLFQVGLGLIHFGFVVTYLSEPLVRGYTTAAAVQVFVSQLKYVFGLHLSSHSGPLSLIYTVLEVCWKLPQSKVGTVVTAAVAGVVLVVVKLLNDKLQQQLPMPIPGELLTLIGATGISYGMGLKHRFEVDVVGNIPAGLVPPVAPNTQLFSKLVGSAFTIAVVGFAIAISLGKIFALRHGYRVDSNQELVALGLSNLIGGIFQCFPVSCSMSRSLVQESTGGNSQVAGAISSLFILLIIVKLGELFHDLPKAVLAAIIIVNLKGMLRQLSDMRSLWKANRADLLIWLVTFTATILLNLDLGLVVAVIFSLLLVVVRTQMPHYSVLGQVPDTDIYRDVAEYSEAKEVRGVKVFRSSATVYFANAEFYSDALKQRCGVDVDFLISQKKKLLKKQEQLKLKQLQKEEKLRKQAASPKGASVSINVNTSLEDMRSNNVEDCKMMQVSSGDKMEDATANGQEDSKAPDGSTLKALGLPQPDFHSLILDLGALSFVDTVCLKSLKNIFHDFREIEVEVYMAACHSPVVSQLEAGHFFDASITKKHLFASVHDAVTFALQHPRPVPDSPVSVTRL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP1577-Ab Anti-S26A6/ SLC26A6 monoclonal antibody
    Target Antigen GM-Tg-g-MP1577-Ag SLC26A6 VLP (virus-like particle)
    ORF Viral Vector pGMLP001573 Human SLC26A6 Lentivirus plasmid
    ORF Viral Vector vGMLP001573 Human SLC26A6 Lentivirus particle


    Target information

    Target ID GM-MP1577
    Target Name SLC26A6
    Gene ID 65010, 171429, 106996923, 301010, 514514, 111768337
    Gene Symbol and Synonyms B930010B04Rik,CFEX,Pat-1,Pat1,SLC26A6
    Uniprot Accession Q9BXS9
    Uniprot Entry Name S26A6_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000225697
    Target Classification Not Available

    This gene belongs to the solute carrier 26 family, whose members encode anion transporter proteins. This particular family member encodes a protein involved in transporting chloride, oxalate, sulfate and bicarbonate. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Aug 2013]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.